Table 1.
Microbiological and clinical responses in 7 dogs with multi-drug resistant infections treated with activated MSC.
| Dog | Infection site | Infection duration prior to study entry | Conncurrent antibiotic | Bacterial species isolated | Clinical response at 8 weeks | Bacteriologic response at 8 weeks |
|---|---|---|---|---|---|---|
| 1 | Post op limb spare surgical site dehiscence | 1 year | Cephalexin | MRSP PR |
Responder−50% wound contraction | Non-responder–Proteus and MRSP decreased by 10% |
| 2 | Post op wound repair dehiscence |
6 weeks | Marbofloxacin, Chloramphenicol | MRSP PA |
Responder−75% wound contraction | Responder–eliminated infection |
| 3 | Post op wound repair dehiscence | 8 weeks | Amoxicillin/ clavulanic acid, Marbofloxacin |
MRSP PA EC |
Responder–fully healed | Responder–eliminated infection |
| 4 | Decubital ulcer | 4 weeks | NA | MRSP | Responder−80% contraction of wound | Non-responder–no change in quantitative count |
| 5 | Wound antebrachium | 8 weeks | Chloramphenicol, Enrofloxacin | MRSP | Responder–fully healed | Responder–eliminated infection |
| 6 | Infection in tibiotarsal joint | 6 months | Clindamycin | MRSP | Responder–joint cytology normal at 8 weeks | Responder–eliminated infection |
| 7 | Nasal infection following radiation therapy | 1 year | Marbofloxacin | MRSP EC, Entc, Strep |
Non-responder−10% improvement in nasal score | Partial responder–eliminated all bacteria but MRSP |
| 8 | Nasal infection following radiation therapy | 1 year | Trimethoprim Sulfamethoxazole | MRSP, EC, Entc, Kleb pn, Crn |
Responder−50% improvement in nasal score | Partial responder–eliminated all bacteria except MRSP and EC |
Organisms isolated from the wounds are abbreviated as follows: MRSP, methicillin resistant Staphylococcus pseudointermedius; EC, Escherichia coli; PA, Pseudomonas aeruginosa; Crn, Corynebacterium species; PR, Proteus species; Ent, Enterobacter species; Entc, Enterococcus species; Strep, Streptococcus species; Kleb pn, Klebsiella pneumoniae.